Spes Unica Medica Sp. z o.o. sp. k. Company Profile - Poland | Financials & Key Executives

Spes Unica Medica Sp. z o.o. sp. k. (Poland)

Main Activities: General Medical and Surgical Hospitals

Secondary Activities: Pharmacies and Drug Stores | Electronic Shopping and Mail-Order Houses | Internet Publishing and Broadcasting and Web Search Portals | Ambulatory Health Care Services | Offices of Physicians | Offices of All Other Miscellaneous Health Practitioners | All Other Miscellaneous Ambulatory Health Care Services | Services for the Elderly and Persons with Disabilities | Other Individual and Family Services

Full name: Spes Unica Medica Sp. z o.o. sp. k.

Profile Updated: November 14, 2024

Spes Unica Medica Sp. z o.o. sp. k. is an enterprise located in Poland, with the main office in Warsaw. The company operates in the General Medical and Surgical Hospitals sector. Spes Unica Medica Sp. z o.o. sp. k. was incorporated on May 14, 2018. The latest financial highlights indicate a net sales revenue increase of 58.16% in 2023. There was a total negative growth of 41.97% in Spes Unica Medica Sp. z o.o. sp. k.’s total assets over the same period. In, 2023, the company’s net profit margin increased by 61.52%.

Headquarters
Ul. Kaliny Jedrusik 9/U2
Warsaw; Mazowieckie; Postal Code: 01-748

Contact Details: Purchase the Spes Unica Medica Sp. z o.o. sp. k. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Spes Unica Medica Sp. z o.o. sp. k. report to view the information.

Incorporation Date:

May 14, 2018

Key Executives

Company Performance

Financial values in the chart are available after Spes Unica Medica Sp. z o.o. sp. k. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

58.16%▲

Total operating revenue

70.58%▲

Operating profit (EBIT)

2.97%▲

EBITDA

37.5%▲

Net Profit (Loss) for the Period

2.97%▲

Total assets

-41.97%▼

Total equity

-21.66%▼

Operating Profit Margin (ROS)

61.52%▲

Net Profit Margin

61.52%▲

Return on Equity (ROE)

-4.52%▼

Similar companies